News
Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...
No, this is not true. Vaccines undergo rigorous safety testing and are continuously monitored for adverse events.
Details of the new rules for COVID-19 vaccine approvals were also outlined in an article published by The New England Journal ...
11h
Medpage Today on MSNFDA Officials Lay Out New COVID Vaccine FrameworkThe FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...
1d
Live Science on MSN2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
The agency will require manufacturers to conduct randomized, controlled trials to secure approval for healthy Americans.
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...
FDA FLAGS SEVERE ITCH — Patients who stop using the oral allergy medicines cetirizine (Zyrtec) or levocetirizine (Xyzal) may ...
The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...
Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...
Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results